首页> 外文期刊>Journal of vascular surgery >Prosthetic stent graft infection after endovascular abdominal aortic aneurysm repair.
【24h】

Prosthetic stent graft infection after endovascular abdominal aortic aneurysm repair.

机译:人工血管支架植入术后血管内腹主动脉瘤修复。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVE: The purpose of this report is to discuss the incidence, diagnosis, and management of stent graft infections after endovascular aneurysm repair (EVAR). METHODS: Data were collected from the hospital database and medical case notes for all patients with infected endografts after elective or emergency EVAR for abdominal aortic aneurysm (AAA) during the last 8 years in two university teaching hospitals in Northern Ireland. The data included the patient's age, gender, presentation of sepsis, treatment offered, and the ultimate outcome. The diagnosis of graft-related sepsis was established by a combination of investigations including inflammatory markers, labelled white cell scan, computed tomography (CT) scan, microbiology cultures, and postmortem examination. RESULTS: Graft-related septic complications occurred in six of 509 patients, including 433 elective repairs and 76 emergency endografts for ruptured AAA. Two patients presented with left psoas abscess and were treated successfully with extra-anatomic bypass and removal of the infected stent graft. Two more patients presented with infected graft without other evidence of intra-abdominal sepsis: one underwent successful removal of the infected prosthesis with extra-anatomical bypass, and the other was treated conservatively and died of progressively worsening sepsis. The fifth patient presented with unexplained fever and died suddenly, with a postmortem diagnosis of aortoenteric fistula and ruptured aneurysm. The last patient presented with an aortoenteric fistula, was treated conservatively in view of concurrent myelodysplasia, and died of possible aneurysm rupture. CONCLUSION: This report emphasizes the need for continued awareness of potential graft-related septic complications in patients undergoing EVAR of AAA. Attention to detail with regard to sterility and antibiotic prophylaxis during stent grafting and during any secondary interventions is vital in reducing the risk of infection. In addition, early recognition and prompt treatment are essential for a successful outcome.
机译:目的:本报告旨在探讨血管内动脉瘤修复(EVAR)后支架移植物感染的发生率,诊断和处理。方法:在过去的8年中,北爱尔兰的两所大学教学医院从医院数据库和所有病例的择期或紧急EVAR腹主动脉瘤(AAA)接受内镜移植后感染病例的医疗案例记录中收集了数据。数据包括患者的年龄,性别,败血症的表现,所提供的治疗以及最终结果。移植物相关败血症的诊断是通过一系列研究确定的,包括炎症标志物,标记的白细胞扫描,计算机断层扫描(CT)扫描,微生物学培养和验尸检查。结果:509例患者中有6例发生了与嫁接相关的败血病并发症,包括433例择期修复和76例因AAA破裂而进行的紧急内移植。两名患者出现左腰大肌脓肿,并接受了解剖外旁路术并移除了感染的支架移植物,从而获得了成功的治疗。另外两名患者出现了移植物感染,而没有其他腹部内脓毒症的证据:一名接受了解剖外旁路术成功移除了受感染的假体,另一名接受了保守治疗,死于脓毒症恶化。第五例患者出现原因不明的发热,突然死亡,死后诊断为主动脉瘘和动脉瘤破裂。最后一名出现主动脉瘘的患者,鉴于并发性骨髓增生异常而接受了保守治疗,并因动脉瘤破裂而死亡。结论:本报告强调需要继续了解接受AAA EVAR的患者潜在的移植物相关败血症并发症。在减少支架感染的过程中以及在进行任何二次干预时,对无菌性和抗生素预防的注意要点至关重要。此外,早期识别和及时治疗对于成功取得成功至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号